FOXO TECHNOLOGIES INC. Profit (Loss) from Real Estate Operations
FOXO TECHNOLOGIES INC. (FOXO) reported Profit (Loss) from Real Estate Operations of $11.29 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProfitLossFromRealEstateOperations · last filed 2023-08-10
- FOXO TECHNOLOGIES INC. profit (loss) from real estate operations for the quarter ending 2023-06-30 was $11.29M.
- FOXO TECHNOLOGIES INC. profit (loss) from real estate operations for the quarter ending 2023-03-31 was $7.64M.
- FOXO TECHNOLOGIES INC. profit (loss) from real estate operations for fiscal 2022 was $95.25M.
| Period end | Profit (Loss) from Real Estate Operations 3 month | Profit (Loss) from Real Estate Operations 6 month | Profit (Loss) from Real Estate Operations 12 month |
|---|---|---|---|
| 2023-06-30 | $11.29M 10-Q · filed 2023-08-10 | $18.93M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $7.64M 10-Q · filed 2023-05-11 | ||
| 2022-12-31 | $95.25M 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |